Allergen-Specific Nasal Challenge: Response Kinetics of Clinical and Inflammatory Events to Rechallenge
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Allergen-specific nasal challenge is a valid and reliable tool for studying the pathophysiological mechanisms involved in allergic inflammation. Nasal challenge induces an immediate clinical response in allergic subjects and a concomitant appearance of an inflammatory infiltrate. The mucosal inflammation may persist up to 48–72 h after allergen exposure. If the subjects are rechallenged within this period the response is more pronounced: the so-defined priming effect. The aim of the study was to evaluate the effects of the nasal rechallenge, performed at different time intervals: 3 days, 1, 2 and 4 weeks after the first challenge. Forty allergic subjects underwent two nasal challenges: at baseline and after the periods mentioned above (10/group). Symptoms and inflammatory cells (eosinophils and neutrophils recovered by nasal brushing) were assessed. The 3-day-interval group showed a hyperreactive response (priming effect), the 1- and 4-week-interval groups showed a response similar to baseline, and the 2-week-interval group showed a hyporeactive response (‘tolerogenic effect’). The last phenomenon may be due to a possible immunologic response similar to that achievable during local specific immunotherapy. The present results further elucidate the kinetics of allergen-driven inflammatory events and highlight the importance of the time period chosen for rechallenge. The latter fact may be of primary importance in clinical trials involving specific challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nasal Immunotherapy to Parietaria: Evidence of Reduction of Local Allergic Inflammation
Passalacqua, G., Albano, M., Ruffoni, S., Pronzato, C., Riccio, A. M., Di Berardino, L., Scordamaglia, A., & Canonica, G. W. (1995) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.152.2.7633693 · Cited by 74
Self-citation
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Self-citationThe diagnosis and management of rhinitis: An updated practice parameter
WALLACE, D., DYKEWICZ, M., BERNSTEIN, D., BLESSINGMOORE, J., COX, L., KHAN, D., LANG, D., NICKLAS, R., OPPENHEIMER, J., & PORTNOY, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.06.003 · Cited by 1,096
Noninjection routes for immunotherapy
Canonica, G. W., & Passalacqua, G. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.129 · Cited by 283
Self-citationEAACI Position paper on the standardization of nasal allergen challenges
Augé, J., Vent, J., Agache, I., Airaksinen, L., Campo Mozo, P., Chaker, A., Cingi, C., Durham, S., Fokkens, W., Gevaert, P., et al. (2018) · Allergy · doi:10.1111/all.13416 · Cited by 269
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study
Marogna, M., Tomassetti, D., Bernasconi, A., Colombo, F., Massolo, A., Rienzo Businco, A. D., Canonica, G. W., Passalacqua, G., & Tripodi, S. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60211-6 · Cited by 234
Self-citation
Metadata
- Authors
- Ciprandi, G., Ricca, V., Landi, M., Passalacqua, G., Bagnasco, M., & Canonica, G. W.
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 1998
- Volume
- 115
- Issue
- 2
- Pages
- 157-161
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2060288367
- Cited by
- 31
- References
- 1
- FWCI
- 0.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.